Some analyses of the IRA's effect on innovation have shown negligible impact. But, a new study developed by Vital Transformation suggests a steep 'pill penalty' for small molecule drugs due to a shorter exclusivity period than for biologics. Today’s ENMEDIA POV policy short features Duane Schulthess, CEO of Vital Transformation. He shares analysis of the research and suggests the EPIC Act could help to address the IRA's challenges. Stay tuned for more from Duane in the weeks ahead. Read findings from the research here: https://lnkd.in/gX6dWSEg
ENTENTE Network
公共关系和沟通服务
ENTENTE Network of Companies: activations, branding, integrated reputation communications, engagement, behavior change
关于我们
ENTENTE Network of Companies encompasses publishing and corporate communications services. We champion innovation-driven organizations in pharma and life sciences, diagnostics, health delivery including digital health and hospital systems, food science, sustainable energy, and social impact.
- 网站
-
https://ententenetwork.com
ENTENTE Network的外部链接
- 所属行业
- 公共关系和沟通服务
- 规模
- 11-50 人
- 总部
- NYC Chicago London Dallas Madison Denver Florida
- 类型
- 私人持股
- 创立
- 2017
- 领域
- executive communications、branding、reputation、public affairs、strategy、consulting、innovation、activation、behavior change、patient engagement、disease awareness、integrated communication、publishing和media
地点
ENTENTE Network员工
-
Julian Leuthold
Founder & CEO at GetGlobal: Thrive in Foreign Markets
-
Jeremy Tunis
"Urgent Care" for Public Affairs, PR, Crisis, Policy. Deep experience with BH/acute hospitals, MedTech, other scrutinized sectors. Jewish nonprofit…
-
Virginia Amann
Strategic and Marketing Communications Leader. Science. Innovation. Founder/CEO/Shareholder ENTENTE Network of Companies
-
Devin Osting
Interim Executive Director of the Alliance for Aviation Across America
动态
-
#ENTENTE was proud to serve as the media relations partner for EBD Group and Demy-Colton's #BiotechShowcase 2025 during #JPMWeek in San Francisco! ? A big thank you to the 80+ media representatives who attended from outlets like Forbes, Reuters, Citeline, and?Fierce Pharma, as well as the many investors and companies we had the opportunity to connect with throughout the event. ? Our CEO, Virginia Amann, moderated the Media Round-Up session, where top journalists shared behind-the-scenes insights into the stories shaping #biotech and #pharma. Special thanks to our incredible panelists: - Alex Philippidis – Genetic Engineering & Biotechnology News - Kyle LaHucik – Endpoints News - Ron Leuty – San Francisco Business Times - Allison DeAngelis – STAT - Adam Bluestein –?Fast Company ? We also want to thank Demy-Colton for ensuring a seamless event and their continued partnership and support.
-
-
Our CEO, Virginia Amann, will moderate the panel, "Media Round-Up: Heard Around the Hilton," during #JPMWeek at the EBD Group and Demy-Colton #BiotechShowcase2025 conference, featuring: - Alex Philippidis, GEN - Kyle LaHucik, Endpoints News - Ron Leuty, San Francisco Business Times - Allison DeAngelis, STAT News - Adam Bluestein, Fast Company This session is open to both conference registrants and non-registrants. Don’t miss this discussion on what was “heard around the square” in #biotech this year. ? RSVP here to secure your spot: bit.ly/3W7XOcu
-
-
Thanks, Casey! As scientists, we often go through graduate school not knowing that there is a whole other world out there away from the academic or industry bench. Hopefully, this sheds some light on the important role of scientists in the life science communications world!
For many, a career in PR begins with a clear-cut path: earning a comms or journalism degree, interning at an agency and then climbing the corporate ladder. But others find value in taking an unconventional route to the field. Professionals such as lawyers, MFA holders, scientists, or accountants bring specialized skills and distinct viewpoints that can greatly enhance agency life. Thank you to Leela Stake (FleishmanHillard), Jeremy Tunis, Katie Morris, PhD and Dave Manzer for taking time to share their experiences on this subject.
-
ENTENTE Network's senior client counsel, Jeremy Tunis, was recently featured in an article by Ragan Communications and PR Daily forecasting media relations trends for 2025. Tunis highlights LinkedIn's growing importance as a public relations tool. As journalists increasingly turn to LinkedIn posts to find potential stories, the platform reshapes the media landscape. ? Read the full article here: https://lnkd.in/e2wWWdkC
-
Hi all. Thanks to everyone who has sent us great talent! Just a reminder to our network that we are hiring for account management, design AND we also just added a marketing communications position. #NowHiring
-
We just released Volume 3 of our print magazine, ENMEDIA. Read our story on the BIOSECURE Act at the link below. #Biotech #Biopharma #HealthcarePolicy https://lnkd.in/gEw7hGde
-
Great story in Endpoints News by NewBiologix Igor Fisch on innovation in gene therapy production and why it matters for patient access of this life changing tech. #genetherapy
The high cost of #GeneTherapies, which can reach more than $4 million per dose, highlights the need for manufacturing solutions that can deliver these life-saving treatments to patients more affordably and at scale. At NewBiologix, we're leading the way with our Xcell? Portfolio, a suite of technologies to streamline rAAV production, improve yield consistency and lower costs. Our CEO, Igor Fisch, Ph.D., discusses these challenges and our innovative solutions in a recent article featured in Endpoints News. By developing stable cell lines to replace transient transfection methods, we’re tackling cost, scalability, and regulatory hurdles, making gene therapies more accessible. Read more: https://lnkd.in/edjeqEK4. #NewBiologix
-
It always feels a little like Christmas morning when we open up a box of fresh ENTENTE Network ENMEDIA Magazines. Excited to share Vol. 3 at the #BioFuture2024 conference this week hosted by Demy-Colton! If this year's BioFuture is anything to go by, the #biotech and #pharma industries are in for an exciting 2025. Looking forward to learning more about emerging technologies and #therapeutics and hope to find some new companies to include in Vol. 4 of our magazine. Please reach out if you would like to be featured! You can read the full version of our magazine here: https://bit.ly/3Aisa4u
-
Fabulous to see our colleague Jeremy Tunis included in Allison Carter's fabulous piece on best writing tips at PR Daily: "Brevity wins every friggin time. Adverbs and passive voice are writing killers if you want people to actually absorb your content." ????
I was blown away by the response to my post asking for communicators' best writing tips -- nearly 300 awesome insights. Here are just a handful of the best.